AZUSA, Calif.--(BUSINESS WIRE)--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has appointed former U.S. Surgeon General, C. Everett Koop, as special advisor to its board of directors. A long-time advocate for public health and AIDS research to spearhead advancements in treatment, Dr. Koop (retired) will advise the board on company decisions surrounding future research and development of immune-based therapies for HIV/AIDS.
